Acamprol: Effective Management for Alcohol Dependence
| Product dosage: 333 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.07 | $62.21 (0%) | 🛒 Add to cart |
| 60 | $1.89 | $124.42 $113.39 (9%) | 🛒 Add to cart |
| 90 | $1.43 | $186.63 $128.44 (31%) | 🛒 Add to cart |
| 120 | $1.19 | $248.85 $142.48 (43%) | 🛒 Add to cart |
| 180 | $1.05
Best per pill | $373.27 $188.64 (49%) | 🛒 Add to cart |
Synonyms | |||
Acamprol is a prescription medication specifically formulated to support individuals in maintaining abstinence from alcohol. It is indicated for use as part of a comprehensive treatment program that includes counseling and psychosocial support. By modulating neurotransmitter activity in the brain, Acamprol helps reduce the craving for alcohol and alleviate the physical and emotional discomfort associated with early abstinence. This medication is intended for patients who have achieved initial alcohol withdrawal and are committed to a sober lifestyle.
Features
- Contains the active ingredient acamprosate calcium
- Delayed-release tablet formulation for sustained effect
- Standard strength of 333 mg per tablet
- Typically packaged in calendarized blister packs to support adherence
- Requires prescription and medical supervision for use
Benefits
- Reduces the urge to consume alcohol, supporting long-term abstinence
- Helps restore natural brain chemical balance disrupted by chronic alcohol use
- Minimizes physical withdrawal symptoms such as restlessness and anxiety
- Non-addictive with no abuse potential
- Compatible with comprehensive addiction treatment programs
- Supports improved quality of life and social functioning
Common use
Acamprol is primarily prescribed for the maintenance of alcohol abstinence in alcohol-dependent patients. Treatment should be initiated as soon as possible after the acute withdrawal period, typically within one week of achieving abstinence. The medication is most effective when used as part of a comprehensive management program that includes psychological support and counseling. Patients should have demonstrated motivation to remain abstinent before beginning treatment.
Dosage and direction
The recommended dosage for most adults is two 333 mg tablets taken three times daily (total 1998 mg/day). Tablets should be swallowed whole with water and not crushed or chewed. Acamprol can be taken with or without food, though consistent administration with meals may help minimize gastrointestinal discomfort. Treatment duration is typically based on individual patient response and should continue even during periods of alcohol abstinence. Dosage adjustment is necessary for patients with renal impairment.
Precautions
Patients should inform their healthcare provider about any kidney problems before starting treatment. Regular monitoring of renal function is recommended during therapy. Acamprol may cause dizziness or visual disturbances—caution should be exercised when driving or operating machinery. Alcohol consumption during treatment may reduce the medication’s effectiveness and is not recommended. Patients should continue participating in support programs throughout treatment.
Contraindications
Acamprol is contraindicated in patients with severe renal impairment (creatinine clearance ≤30 mL/min). It should not be used during pregnancy unless clearly necessary and under strict medical supervision. The medication is not recommended for patients with known hypersensitivity to acamprosate calcium or any excipients in the formulation. Use is not indicated for patients who have not undergone alcohol withdrawal.
Possible side effects
Common side effects may include diarrhea, nausea, abdominal pain, and itching. Some patients may experience headache, dizziness, fatigue, or insomnia. Less frequently reported effects include changes in libido, depression, anxiety, and skin reactions. Most side effects are mild to moderate and often diminish with continued treatment. Patients should report persistent or severe symptoms to their healthcare provider.
Drug interaction
No clinically significant pharmacokinetic interactions have been established with medications commonly used in alcohol dependence treatment. However, caution is advised when combining Acamprol with other centrally acting drugs. Concurrent use with naltrexone may potentially enhance therapeutic effects, though this combination should be monitored by a healthcare professional. Always inform your doctor about all medications, including over-the-counter drugs and supplements.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed one. Maintain regular dosing schedule to ensure consistent therapeutic levels. If multiple doses are missed, contact your healthcare provider for guidance on resuming treatment.
Overdose
Cases of overdose have been reported with symptoms including gastrointestinal distress, dizziness, and diarrhea. No specific antidote exists—treatment should be symptomatic and supportive. Hemodialysis may be considered in severe cases, particularly in patients with renal impairment. In case of suspected overdose, seek immediate medical attention or contact a poison control center.
Storage
Store at room temperature (15-30°C) in the original container. Keep tightly closed and protect from moisture. Do not use after the expiration date printed on the packaging. Keep out of reach of children and pets. Do not transfer tablets to other containers as the calendarized packaging helps maintain treatment adherence.
Disclaimer
This information is provided for educational purposes only and does not replace professional medical advice. Always consult with a qualified healthcare provider before starting or changing any treatment regimen. Individual response to medication may vary, and proper medical supervision is essential throughout treatment.
Reviews
Clinical studies demonstrate that Acamprol significantly improves abstinence rates compared to placebo when used as part of a comprehensive treatment program. Many patients report reduced alcohol craving and improved ability to maintain sobriety. Healthcare professionals note that the medication is generally well-tolerated with a favorable safety profile. Long-term follow-up studies indicate sustained benefits for patients who remain compliant with treatment.